Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02306603 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Long-term Outcomes of Endoscopic Resection (ER) of Lesions of the Duodenum and Ampulla

Study acronym: OERDA
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Site contact updatedv11
  2. Re-verified, no change to tracked fieldsv10
  3. Primary completion date: Oct 2021 to Oct 2026
    • Study completion date: Oct 2022 to Apr 2027
    v9
  4. Primary completion date: Oct 2020 to Oct 2021
    • Study completion date: Oct 2020 to Oct 2022
    • Site contact updated
    v8
  5. Primary completion date: Oct 2019 to Oct 2020v7
Show 5 earlier versionsHide 5 earlier versions
  1. Primary completion date: Oct 2018 to Oct 2019
    • Study completion date: Oct 2019 to Oct 2020
    v6
  2. 4 versions Re-verified since Dec 3, 2014, no change to tracked fieldsv2-v5
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This research project, 'Outcomes of endoscopic resection of mucosal and submucosal lesions in the duodenum and ampulla'. The research project is aiming to determine the most effective and safe way to remove such lesions.
Trial Details
NCT Number NCT02306603
Lead Sponsor Professor Michael Bourke
Conditions
(from sponsor)		 Adenoma, Villous
Related terms Adenoma, Villous
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov